SOPH Stock Price | Sophia Genetics SA P/E, Revenue, EPS, & Forecasts

Sophia Genetics SA • SOPH

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Sophia Genetics SA

Ticker

SOPH

Trading on

NASDAQ

ISIN

CH1125843347

Industry

Health Information Services

Sector

Healthcare

CEO

Dr. Jurgi Camblong M.B.A., Ph.D.

Headquarters

La Pièce 12, Rolle, undefined, Switzerland, 1180

Employees

423

Website

sophiagenetics.com

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.

Metrics

BasicAdvanced

Market cap

$203M

P/E ratio

EPS

-$1.00

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-62.2M

Ex dividend date

Price & volume

Market cap

$203M

Average daily volume

0.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

3.03

Price to book

2.38

Earnings

EPS

-$1.00

EPS estimate (current quarter)

-$0.20

EPS estimate (next quarter)

-$0.17

EBITDA

$-62.2M

Revenues (TTM)

$67.2M

Revenues per share (TTM)

$1.01

Technicals

Beta

52-week High

$4.92

52-week Low

$2.58

50-day moving average

$2.97

200-day moving average

$3.36

Short ratio

1.34

Short %

0.06%

Management effectiveness

ROE (TTM)

-60.75%

ROA (TTM)

-24.41%

Profit margin

-98.51%

Gross profit margin

$45.7M

Operating margin

-90.20%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

12.70%

Share stats

Outstanding Shares

66.8M

Float

46.6M

Insiders %

6.53%

Institutions %

58.81%

Analyst Insights & forecasts

84% Buy

16% Hold

0% Sell

Based on information from 6 analysts.

Average price target

$6.80

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.23

-$0.28

17.86%

Q2 • 24Beat

-$0.28

-$0.23

-20.78%

Q3 • 24Missed

-$0.12

-$0.15

20.07%

Q4 • 24Beat

-$0.26

-$0.20

-33.38%

Q1 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$17.7M

$-15.2M

-85.48%

Q4 • 24

$17.8M

$-17.4M

-97.78%

Q1 • 25

0.26%

14.69%

14.40%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$155M

$58.8M

37.87%

Q4 • 24

$147M

$61.1M

41.65%

Q1 • 25

-5.53%

3.89%

9.97%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-10.6M

$-1.9M

$-0.6M

$-12.5M

Q4 • 24

$-10.8M

$-1M

$-12.2M

Q1 • 25

1.41%

-46.44%

72.77%

-2.39%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Sophia Genetics SA share?

Sophia Genetics SA shares are currently traded for undefined per share.

How many shares does Sophia Genetics SA have?

Sophia Genetics SA currently has 66.8M shares.

Does Sophia Genetics SA pay dividends?

No, Sophia Genetics SA doesn't pay dividends.

What is Sophia Genetics SA 52 week high?

Sophia Genetics SA 52 week high is $4.92.

What is Sophia Genetics SA 52 week low?

Sophia Genetics SA 52 week low is $2.58.

What is the 200-day moving average of Sophia Genetics SA?

Sophia Genetics SA 200-day moving average is $3.36.

Who is Sophia Genetics SA CEO?

The CEO of Sophia Genetics SA is Dr. Jurgi Camblong M.B.A., Ph.D..

How many employees Sophia Genetics SA has?

Sophia Genetics SA has 423 employees.

What is the market cap of Sophia Genetics SA?

The market cap of Sophia Genetics SA is $203M.

What is the P/E of Sophia Genetics SA?

The current P/E of Sophia Genetics SA is null.

What is the EPS of Sophia Genetics SA?

The EPS of Sophia Genetics SA is -$1.00.

What is the PEG Ratio of Sophia Genetics SA?

The PEG Ratio of Sophia Genetics SA is null.

What do analysts say about Sophia Genetics SA?

According to the analysts Sophia Genetics SA is considered a buy.